Concepedia

Frank Pistrosch

FP

Statistics

Publications

36

Citations

6.9K

H-Index

29

Active since

2001

Affiliations

University Hospital Carl Gustav Carus(Current)

Technische Universität Dresden

Klinik und Poliklinik für Psychotherapie und Psychosomatik

GWT-TUD (Germany)

University of Chicago

Frank Pistrosch is an author at University Hospital Carl Gustav Carus specializing in medicine, pharmacology, and diabetology.

ORCID

Publications per year

2001–2023

36

Publications

36

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

, , +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

, , +15

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

, , +10

Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine

Julian Stumpf, Torsten Siepmann, Tom H. Lindner et al. · The Lancet Regional Health - Europe · 2021 · 309 citations · Full text

, , +17

In Type 2 Diabetes, Rosiglitazone Therapy for Insulin Resistance Ameliorates Endothelial Dysfunction Independent of Glucose Control

Frank Pistrosch, Jens Passauer, Sabine Fischer et al. · Diabetes Care · 2004 · 230 citations · Full text

, , +17

1–5 of 36